Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Mayumi Nakagawa

Concepts (217)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Papillomavirus Infections
15
2024
155
4.740
Why?
Human papillomavirus 16
11
2021
44
3.730
Why?
Uterine Cervical Neoplasms
10
2024
275
3.470
Why?
Papillomavirus Vaccines
7
2021
61
3.410
Why?
Oncogene Proteins, Viral
11
2011
52
2.540
Why?
Papillomaviridae
7
2019
102
2.400
Why?
Repressor Proteins
9
2011
153
2.160
Why?
Epitopes, T-Lymphocyte
7
2018
24
1.970
Why?
Cancer Vaccines
3
2021
78
1.660
Why?
T-Lymphocytes
6
2021
339
1.460
Why?
Candida
4
2018
60
1.380
Why?
CD8-Positive T-Lymphocytes
6
2018
127
1.340
Why?
Cervix Uteri
3
2021
49
0.910
Why?
Uterine Cervical Dysplasia
2
2015
49
0.860
Why?
Immunity, Cellular
4
2013
70
0.760
Why?
Lymphocytes, Tumor-Infiltrating
1
2021
78
0.740
Why?
Epitopes
2
2015
61
0.730
Why?
Langerhans Cells
3
2018
11
0.720
Why?
Neoplasms
2
2021
1250
0.690
Why?
Viral Load
2
2019
76
0.680
Why?
Health Education
1
2021
153
0.670
Why?
Cell Cycle Checkpoints
1
2019
32
0.660
Why?
HLA Antigens
4
2006
53
0.640
Why?
Colorectal Neoplasms
1
2021
238
0.610
Why?
CD4-Positive T-Lymphocytes
3
2018
163
0.580
Why?
Humans
40
2024
50251
0.580
Why?
Adult
20
2021
13384
0.580
Why?
Female
28
2024
26668
0.570
Why?
Health Knowledge, Attitudes, Practice
1
2021
486
0.550
Why?
Plasma Exchange
2
2014
23
0.530
Why?
Cross Protection
1
2015
5
0.510
Why?
T-Lymphocytes, Regulatory
2
2016
86
0.510
Why?
Colposcopy
1
2015
18
0.490
Why?
Interleukin-12
2
2018
31
0.490
Why?
Adjuvants, Immunologic
2
2018
51
0.480
Why?
Immunity, Innate
1
2015
105
0.470
Why?
Interferon-gamma
2
2012
176
0.460
Why?
Health
1
2013
22
0.460
Why?
Lectins, C-Type
1
2013
30
0.450
Why?
Papillomavirus E7 Proteins
8
2018
31
0.450
Why?
Young Adult
9
2021
4002
0.440
Why?
Patient Selection
1
2015
252
0.440
Why?
Middle Aged
14
2021
12234
0.430
Why?
Afibrinogenemia
1
2012
5
0.420
Why?
Enzyme-Linked Immunospot Assay
1
2012
2
0.410
Why?
T-Lymphocytes, Cytotoxic
4
2009
65
0.410
Why?
Breast Neoplasms
1
2021
1184
0.400
Why?
Vaginal Smears
3
2021
27
0.380
Why?
Cell Proliferation
5
2021
1015
0.380
Why?
Early Detection of Cancer
3
2021
168
0.370
Why?
Warts
1
2010
13
0.370
Why?
Plateletpheresis
1
2010
7
0.370
Why?
Antigens, Fungal
1
2010
24
0.370
Why?
Blood Preservation
1
2010
26
0.370
Why?
Dermatitis
1
2010
36
0.360
Why?
Blood Proteins
1
2010
82
0.360
Why?
Anaphylaxis
1
2010
71
0.350
Why?
Cells, Cultured
5
2021
1583
0.330
Why?
Antigens, Viral
2
2009
44
0.320
Why?
Immunotherapy
1
2010
240
0.320
Why?
Telemedicine
1
2015
459
0.310
Why?
Human papillomavirus 18
1
2008
9
0.310
Why?
Blood Platelets
1
2010
249
0.300
Why?
Host-Pathogen Interactions
2
2021
135
0.290
Why?
Vaccinia virus
1
2007
6
0.290
Why?
Dendritic Cells
1
2008
133
0.290
Why?
Immunoenzyme Techniques
1
2007
145
0.280
Why?
Immunophenotyping
1
2007
110
0.280
Why?
Isoantibodies
1
2004
25
0.240
Why?
Cell Line, Tumor
5
2021
1418
0.240
Why?
Neoplasm Grading
2
2021
123
0.240
Why?
Aged
9
2021
9427
0.240
Why?
Lead
1
2004
34
0.240
Why?
Infant, Very Low Birth Weight
1
2004
47
0.230
Why?
Neutropenia
1
2004
115
0.230
Why?
DNA, Viral
3
2011
134
0.230
Why?
Oropharyngeal Neoplasms
1
2024
19
0.230
Why?
Anus Neoplasms
1
2024
24
0.230
Why?
Coinfection
1
2024
41
0.220
Why?
Blood Transfusion
1
2004
131
0.220
Why?
Penile Neoplasms
1
2024
45
0.220
Why?
Adolescent
5
2021
6402
0.220
Why?
High-Throughput Nucleotide Sequencing
2
2021
171
0.220
Why?
Capsid Proteins
1
2002
24
0.210
Why?
Antibody Formation
1
2002
51
0.210
Why?
Genes, T-Cell Receptor
1
2021
5
0.200
Why?
Clone Cells
3
2007
78
0.200
Why?
Treatment Outcome
3
2021
5186
0.200
Why?
Clinical Trials, Phase I as Topic
1
2021
25
0.200
Why?
Cytokines
2
2016
615
0.200
Why?
Pilot Projects
2
2021
704
0.190
Why?
Remission Induction
1
2021
207
0.190
Why?
Mass Screening
2
2021
346
0.190
Why?
Cystadenocarcinoma, Serous
1
2021
71
0.190
Why?
Left-Right Determination Factors
1
2020
1
0.190
Why?
Lymphocyte Activation
1
2021
171
0.190
Why?
Nodal Protein
1
2020
3
0.190
Why?
Videotape Recording
1
2021
27
0.190
Why?
Amino Acid Sequence
3
2008
587
0.180
Why?
Mammography
1
2021
94
0.180
Why?
Focus Groups
1
2021
192
0.170
Why?
Enzyme-Linked Immunosorbent Assay
3
2010
244
0.170
Why?
Male
10
2024
25483
0.170
Why?
Metagenome
1
2019
40
0.170
Why?
Glioblastoma
1
2020
93
0.160
Why?
Parenteral Nutrition
1
2019
27
0.160
Why?
Feasibility Studies
1
2021
382
0.160
Why?
Dose-Response Relationship, Drug
2
2016
1377
0.160
Why?
Up-Regulation
1
2020
452
0.160
Why?
Health Behavior
1
2021
252
0.160
Why?
Transplantation Conditioning
1
2019
84
0.160
Why?
DNA
1
2021
542
0.150
Why?
Time Factors
2
2021
2911
0.150
Why?
Bacteria
1
2019
221
0.150
Why?
Leukocytes, Mononuclear
2
2016
115
0.150
Why?
HLA-B Antigens
2
2008
6
0.150
Why?
Multiple Myeloma
1
2012
2958
0.150
Why?
Age Factors
1
2021
1088
0.150
Why?
Cell Line
2
2012
1024
0.140
Why?
Ovarian Neoplasms
1
2021
448
0.140
Why?
Brain Neoplasms
1
2020
289
0.140
Why?
Histocompatibility Antigens Class II
2
2008
36
0.140
Why?
Vaccines, Subunit
1
2016
15
0.130
Why?
Head and Neck Neoplasms
1
2019
294
0.130
Why?
Body Mass Index
1
2019
654
0.130
Why?
Molecular Sequence Data
2
2008
793
0.130
Why?
Adaptive Immunity
1
2015
31
0.130
Why?
Chromatography, Liquid
1
2016
224
0.120
Why?
Leukocyte Count
2
2004
72
0.120
Why?
Peptides
2
2006
223
0.120
Why?
Tandem Mass Spectrometry
1
2016
230
0.120
Why?
Factor VIII
1
2014
23
0.120
Why?
Purpura, Thrombotic Thrombocytopenic
1
2014
15
0.120
Why?
ADAM Proteins
1
2014
20
0.120
Why?
Proteome
1
2016
174
0.120
Why?
Antigens, CD1
1
2013
9
0.120
Why?
Mannose-Binding Lectins
1
2013
10
0.120
Why?
Receptors, Pattern Recognition
1
2013
4
0.120
Why?
Indicators and Reagents
1
2013
37
0.110
Why?
Intracellular Space
1
2013
25
0.110
Why?
Skin Tests
1
2013
57
0.110
Why?
Vaccination
1
2016
273
0.110
Why?
Hematopoietic Stem Cell Transplantation
1
2019
567
0.110
Why?
Cadherins
1
2013
68
0.110
Why?
Proteomics
1
2016
327
0.110
Why?
Communication
1
2015
246
0.110
Why?
Rural Health Services
1
2015
164
0.100
Why?
Research Design
1
2015
343
0.100
Why?
Socioeconomic Factors
1
2015
580
0.100
Why?
Antigens, CD
1
2013
221
0.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
594
0.100
Why?
Longitudinal Studies
2
2005
687
0.100
Why?
Injections, Intralesional
1
2010
31
0.090
Why?
Isotonic Solutions
1
2010
18
0.090
Why?
Platelet Transfusion
1
2010
28
0.090
Why?
P-Selectin
1
2010
32
0.090
Why?
Sodium Chloride
1
2010
58
0.090
Why?
Platelet Aggregation
1
2010
71
0.090
Why?
Platelet Activation
1
2010
47
0.090
Why?
Hypersensitivity
1
2010
77
0.090
Why?
Retrospective Studies
3
2019
6172
0.080
Why?
Polymerase Chain Reaction
1
2010
455
0.080
Why?
HLA-A Antigens
1
2008
10
0.080
Why?
Antigen Presentation
1
2008
25
0.080
Why?
Immunologic Memory
1
2008
30
0.080
Why?
Histocompatibility Antigens Class I
1
2008
44
0.080
Why?
Signal Transduction
2
2020
1624
0.070
Why?
DNA, Recombinant
1
2007
15
0.070
Why?
Genes, MHC Class I
1
2006
11
0.070
Why?
Animals
2
2019
13285
0.070
Why?
Arkansas
1
2013
1962
0.070
Why?
Binding, Competitive
1
2006
94
0.070
Why?
Neoplasm Staging
1
2008
747
0.060
Why?
Calgranulin B
1
2005
4
0.060
Why?
Calgranulin A
1
2005
5
0.060
Why?
Immunomagnetic Separation
1
2004
7
0.060
Why?
Epitope Mapping
1
2004
6
0.060
Why?
Risk Factors
1
2013
3608
0.060
Why?
Phosphorylation
2
2020
534
0.050
Why?
Sensitivity and Specificity
1
2005
869
0.050
Why?
Tumor Virus Infections
1
2002
42
0.050
Why?
Antibodies, Viral
1
2002
88
0.050
Why?
Lactobacillus
1
2021
6
0.050
Why?
Immunoglobulin G
1
2002
186
0.050
Why?
SOX Transcription Factors
1
2021
4
0.050
Why?
Neuroendocrine Cells
1
2021
10
0.050
Why?
Biological Specimen Banks
1
2021
21
0.050
Why?
Cytodiagnosis
1
2021
42
0.050
Why?
Cytoplasm
1
2021
91
0.050
Why?
Cobalt
1
2020
16
0.050
Why?
Cohort Studies
1
2004
1397
0.050
Why?
Recurrence
1
2002
661
0.040
Why?
Vulnerable Populations
1
2020
46
0.040
Why?
Epithelial-Mesenchymal Transition
1
2020
48
0.040
Why?
Cell Hypoxia
1
2020
82
0.040
Why?
Neoplastic Stem Cells
1
2021
103
0.040
Why?
Cell Movement
1
2021
249
0.040
Why?
Community Health Workers
1
2020
52
0.040
Why?
Multivariate Analysis
1
2021
578
0.040
Why?
Parenteral Nutrition, Total
1
2019
31
0.040
Why?
Sequence Analysis, DNA
1
2019
238
0.040
Why?
Cell Survival
1
2020
602
0.040
Why?
Phenotype
1
2021
732
0.040
Why?
Cell Differentiation
1
2021
652
0.040
Why?
Linear Models
1
2019
276
0.040
Why?
Immunity, Humoral
1
2018
22
0.040
Why?
Models, Biological
1
2021
726
0.040
Why?
Infant, Newborn
1
2004
2767
0.040
Why?
Gene Expression Regulation, Neoplastic
1
2020
828
0.030
Why?
Prognosis
1
2021
1959
0.030
Why?
Autoantibodies
1
2014
116
0.030
Why?
Immunosuppressive Agents
1
2014
223
0.030
Why?
Mice, Inbred C57BL
1
2018
1823
0.030
Why?
Combined Modality Therapy
1
2014
641
0.030
Why?
Mice
1
2018
5770
0.020
Why?
Casein Kinase II
1
2005
10
0.020
Why?
Cell Division
1
2005
295
0.010
Why?
Nakagawa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description